Works matching IS 10837159 AND DT 2023 AND VI 28 AND IP 4

Results: 21
    1
    2
    3
    4
    5

    KRAS: Druggable at Last.

    Published in:
    Oncologist, 2023, v. 28, n. 4, p. 283, doi. 10.1093/oncolo/oyad014
    By:
    • Herzberg, Benjamin O;
    • Manji, Gulam A
    Publication type:
    Article
    6
    7
    8
    9
    10

    Feasibility of a Geriatric Oncology Longitudinal End to End (GOLDEN) Program in a Tertiary Cancer Center in Singapore.

    Published in:
    Oncologist, 2023, v. 28, n. 4, p. e198, doi. 10.1093/oncolo/oyac276
    By:
    • Ho, Francis;
    • Kow, Alfred;
    • Lim, Wan Chin;
    • Chen, Matthew Zhixuan;
    • Rais, Nydia Camelia Mohd;
    • Ling, Natalie Mun Wai;
    • Ooi, Melissa;
    • Ng, Jing Yu;
    • Ng, Yean Shin;
    • Chun, Meiling;
    • Yao, Yao;
    • Said, Noorhanah Mohd;
    • Eng, Wan Nghee;
    • Chen, Wen Meei;
    • Luah, Vivian;
    • Loy, Yijun;
    • Ong, Jiexin;
    • Wong, Wei Yee;
    • Korc-Grodzicki, Beatriz;
    • Lichtman, Stuart M
    Publication type:
    Article
    11

    Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis.

    Published in:
    Oncologist, 2023, v. 28, n. 4, p. 327, doi. 10.1093/oncolo/oyac273
    By:
    • Dodoo, Grace N;
    • De, Brian;
    • Lee, Sunyoung S;
    • Jaoude, Joseph Abi;
    • Vauthey, Jean-Nicolas;
    • Tzeng, Ching-Wei D;
    • Cao, Hop S Tran;
    • Katlowitz, Kalman A;
    • Mandel, Jacob J;
    • Beckham, Thomas H;
    • Minsky, Bruce D;
    • Smith, Grace L;
    • Holliday, Emma B;
    • Koong, Albert C;
    • Das, Prajnan;
    • Taniguchi, Cullen M;
    • Javle, Milind;
    • Koay, Eugene J;
    • Ludmir, Ethan B
    Publication type:
    Article
    12
    13
    14
    15
    16
    17

    Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies.

    Published in:
    Oncologist, 2023, v. 28, n. 4, p. 341, doi. 10.1093/oncolo/oyac251
    By:
    • Chaudhary, Surendra Pal;
    • Reyes, Stephanie;
    • Chase, Matthew L;
    • Govindan, Aparna;
    • Zhao, Lei;
    • Luther, Jay;
    • Bhan, Irun;
    • Bethea, Emily;
    • Franses, Joseph W;
    • Walsh, Elizabeth Paige;
    • Dageford, Leigh Anne;
    • Kimura, Shoko;
    • Elias, Nahel;
    • Yeh, Heidi;
    • Markman, James;
    • Bozorgzadeh, Adel;
    • Tanabe, Kenneth;
    • Ferrone, Cristina;
    • Zhu, Andrew X;
    • Andersson, Karin
    Publication type:
    Article
    18

    Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors.

    Published in:
    Oncologist, 2023, v. 28, n. 4, p. 364, doi. 10.1093/oncolo/oyac244
    By:
    • Gatti-Mays, Margaret E;
    • Tschernia, Nicholas P;
    • Strauss, Julius;
    • Madan, Ravi A;
    • Karzai, Fatima H;
    • Bilusic, Marijo;
    • Redman, Jason;
    • Sater, Houssein Abdul;
    • Floudas, Charalampos S;
    • Toney, Nicole J;
    • Donahue, Renee N;
    • Jochems, Caroline;
    • Marté, Jennifer L;
    • Francis, Deneise;
    • McMahon, Sheri;
    • Lamping, Elizabeth;
    • Cordes, Lisa;
    • Schlom, Jeffrey;
    • Gulley, James L
    Publication type:
    Article
    19

    Avelumab Plus Axitinib as First-Line Therapy for Advanced Renal Cell Carcinoma: Long-Term Results from the JAVELIN Renal 100 Phase Ib Trial.

    Published in:
    Oncologist, 2023, v. 28, n. 4, p. 333, doi. 10.1093/oncolo/oyac243
    By:
    • Larkin, James;
    • Oya, Mototsugu;
    • Martignoni, Marcella;
    • Thistlethwaite, Fiona;
    • Nathan, Paul;
    • Ornstein, Moshe C;
    • Powles, Thomas;
    • Beckermann, Kathryn E;
    • Balar, Arjun V;
    • McDermott, David;
    • Gupta, Sumati;
    • Philips, George K;
    • Gordon, Michael S;
    • Uemura, Hirotsugu;
    • Tomita, Yoshihiko;
    • Wang, Jing;
    • Michelon, Elisabete;
    • Pietro, Alessandra di;
    • Choueiri, Toni K
    Publication type:
    Article
    20
    21